Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2018-01-18 Declaration of Voting R…
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details the acquisition/disposal of shares with voting rights by Allianz SE and its subsidiaries, crossing a threshold on December 21, 2017. This directly corresponds to the definition of a notification of changes in significant share ownership levels, which maps to the Major Shareholding Notification code (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a specific disclosure of major holdings, which is better classified as MRQ than DVA (which is for voting results) or RNS (which is a fallback).
2018-01-18 English
Entsprechenserklärung 2017
Governance Information Classification · 1% confidence The document is titled "Entsprechenserklärung 2017" (Declaration of Conformity 2017) and explicitly states it is the declaration by the Management Board and Supervisory Board of STRATEC Biomedical AG regarding compliance with the recommendations of the German Corporate Governance Code ("Deutscher Corporate Governance Kodex"). This type of declaration, which details adherence or deviations from governance standards, directly relates to the company's internal rules, board structure, and governance practices. This aligns perfectly with the definition for Governance Information (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or a Remuneration Report (DEF 14A), although it discusses remuneration (Ziffer 4.2.5). The core purpose is governance compliance declaration.
2017-12-15 German
Declaration of Compliance 2017
Governance Information Classification · 1% confidence The document is explicitly titled "CORPORATE GOVERNANCE DECLARATION 2017" and details the company's conformity (or deviations) with the recommendations of the German Corporate Governance Code (DCGK). This content directly relates to the company's internal rules, board structure, and governance practices, which aligns perfectly with the definition for Governance Information (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or a general Earnings Release (ER).
2017-12-15 English
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Total Voting Rights Announcement' and explicitly mentions the 'Publication of total number of voting rights'. It details a 'Conditional capital increase' and provides the 'New total number of voting rights' (11,920,945). This content directly relates to changes in the company's capital structure and the resulting voting power, which aligns best with the 'Capital/Financing Update' (CAP) category, as it announces a change in capital that affects voting rights. While it touches upon voting rights, it is fundamentally about a capital measure (conditional increase) rather than just reporting the final vote tally (DVA) or general insider trading (DIRS). Given the focus on the capital measure, CAP is the most precise fit.
2017-11-30 English
Conference Call Quarterly Statement 9M|2017
Investor Presentation Classification · 1% confidence The document is a presentation titled '9M 2017 Financial Results' intended for a conference call. It contains detailed financial highlights, tables of key figures (Sales, EBITDA, EBIT, EPS), cash flow analysis, and forward-looking guidance. It is structured as a slide deck for investors, which aligns with the definition of an Investor Presentation (IP). 9M 2017
2017-11-15 English
STRATEC continues to deliver growth in the first nine months 2017
Earnings Release Classification · 1% confidence The document explicitly states it is announcing the financial results for the period from January 1, 2017, through to September 30, 2017, with the publication of its 'Quarterly Statement 9M|2017'. It contains key financial figures (Sales, EBITDA, EBIT, Net Income) for the 9-month period and the third quarter (Q3|2017). This content aligns perfectly with the definition of an Interim/Quarterly Report (IR). Although it is distributed via a news service (DGAP), the core content is the comprehensive financial statement for an interim period, not just a brief announcement of its release (which would be RPA/RNS). 9M 2017
2017-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.